Cytokinetics | CYTK - Equity Capital And Reserves


Cytokinetics reported $-521.12M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Acadia Pharmaceuticals USD 917.27M 94.89M Sep/2025
Amgen USD 9.62B 2.19B Sep/2025
Bayer EUR 29.7B 799M Sep/2025
Biogen USD 18.21B 573.5M Sep/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Cytokinetics USD -521.12M 216.32M Sep/2025
Eisai JPY 854.43B 25.92B Sep/2025
Eli Lilly USD 23.79B 5.52B Sep/2025
Exelixis USD 2.16B 127.16M Sep/2025
Geron USD 248.71M 10.82M Sep/2025
Halozyme Therapeutics USD 503.92M 171.17M Sep/2025
Ionis Pharmaceuticals USD 617.97M 13.76M Sep/2025
Ligand Pharmaceuticals USD 950.17M 121.64M Sep/2025
Merck USD 51.85B 2.79B Sep/2025
Novartis USD 44.75B 2.7B Sep/2025
Pfizer USD 92.8B 4.11B Sep/2025
Regeneron Pharmaceuticals USD 31.26B 299.1M Dec/2025
Roche Holding CHF 33.8B 758M Dec/2025
Sanofi EUR 71.71B 1.55B Dec/2025